Grading and staging chronic hepatitis C and its relation to genotypes and epidemiological factors in Brazilian blood donors

Brazilian Journal of Infectious Diseases

Volumn 9, Issue 2, 2005, Pages 142-149

  Silva, Giovanni Faria ^a   Nishimura, Nancy F ^b   Coelho, Kunie Iabuki Rabello ^a   Soares, Elza Cotrim ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b NONE

Author keywords

Fibrosis; Hepatitis C; Risk factors

Indexed keywords

AMINOTRANSFERASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD DONOR; BRAZIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; STAGING; STATISTICAL ANALYSIS; VIRUS TRANSMISSION; BLOOD; DISEASE COURSE; GENETICS; HEPATITIS C VIRUS; IMMUNOLOGY; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; VIROLOGY;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD DONORS; BRAZIL; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; RNA, VIRAL;

EID: 26944465461     PISSN: 14138670     EISSN: 14138670     Source Type: Journal    
DOI: 10.1590/S1413-86702005000200004     Document Type: Article

References (29)

1. Wasley A., Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000;20(1):1-16.
2. Kiyosawa K., Sodeyama T., Tanaka E., et al. Interrelationship of blood transfusion, non A, non B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
3. Serfaty L., Aumaitre H., Chauzouilleres, et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998,27:1435-40.
4. Di Bisceglie A.M. Natural history of hepatitis C: Its impact on clinical management. Hepatology 2000;31(4):1014-8.
5. Alter H.J., Seeff L.B. Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on longterm outcome. Semin Liver Dis 2000;20(1):17-35.
6. Martinot-Peignoux M., Roudot-Thoraval F., Mendel I., et al. The GEMHEP. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to Interferon therapy. J Viral Hepat 1999;6(6):435-43.
7. Bellentani S., Pozzato G., Saccoccio G., et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: Report from the Dionysios study. Gut 1999;44(6):874-80.
8. EASL International Consensus Conference on hepatitis C. Consensus Statement. J Hepatol 1999;30:956-61.
9. Matsumura H., Moriyama M., Goto I., et al. Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C: a study of 527 patients at one establishment. J Viral Hepat 2000;7(4):268-75.
10. Bedossa P., Poynard T. METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24(2):289-93.
11. Poynard T., Ratziu V, Benmanov Y., et al. Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis 2000;20(1):47-55.
12. Poynard T., Bedossa P., Opolon P., for the OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
13. Stuyver L., Wysens A., Hernandez F., et al. Second generation Line Probe Assay for hepatitis C virus genotyping. J Clin Microbiol 1996;2259-66.
14. Desmet V.J., Gerber M., Hoofnagle J.H., et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
15. Gayotto L.C.C., Comitê SBP/SBH. Visão histórica e consenso nacional sobre a classificação das hepatites crônicas. Gastroenterologia Endoscopia Digestiva 2000;19(3):137-40.
16. Murphy E.L., Brysman S., Willians A.E., et al. Demographic determinants of hepatitis C virus: seroprevalence among blood donors. JAMA 1996;275(13):995-9.
17. Alter M.J. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995;15(1):5-14.
18. Khan M.H., Farrel G.C., Byth K., et al. Which patients with hepatitis C develop liver complications? Hepatology 2000;31(2):515-20.
19. Lima J.P., Lima J.C.P., Peter R. Anti-corpos séricos do VHC: análise dos fatores de risco da soropositividade, avaliaçaão bioquímica e histológica do fígado numa população de doadores de doadores voluntários de sangue em Porto Alegre. Gastroenterologia Endoscopia Digestiva 1995;14(5):201-12.
20. Bassit L., Da Silva L.C., Ribeirodos Santos G., et al. Chronic hepatitis C virus infection in Brazilian patients: association with genotypes, clinical parameters and response to long term alpha-interferon therapy. Rev Inst Med Trop São Paulo 1999;41(3):183-9.
21. Murphy E.L., Brysman S.M., Glynn S.A., et al. Risck factors for hepatitis C virus infection in United States blood donors. Hepatology 2000;31(3):756-62.
22. Maio G., Argenio P., Stroffolini T., et al. Hepatitis C infection and alanine transaminasis levels in the general population: a survey in a southern Italian town. J Hepatol 2000;33(1):116-20.
23. Noguchi S., Sata M., Suzuki H., et al. Routes of transmission of hepatitis C virus in a epidemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection. Scand J Infect Dis 1997;29:23-8.
24. Saracco G., Sostegni R., Ghisetti V., et al. Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre study. J Viral Hepat 2000;7(2):124-9.
25. Adinolfi L.E., Utili R., Andreana A., et al. Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients. Eur J Gastroenterol Hepatol 2000;12(3):299-304.
26. Booth J.C.L., Foster G.R., Levine T., et al. The relationship of histology to genotype in chronic HCV infection. Liver 1997;17(3):144-51.
27. Ramalho F., Costa A., Pires A., et al. Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C. Dig Dis Sci 2000;45(1):182-7.
28. Gordon S.C., Bayati N., Silverman A.L. Clinical outcome of hepatitis C as a function of mode of transmission. Hepatology 1998;28(2):562-7.
29. Niederau C., Lange S., Heitges T., et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998;28(6):1687-95.